retatrutide clinical trial sites Retatrutide, an investigational triple hormone receptor agonist that shows promise for weight loss in ongoing phase-3 trials, is being sold openly across the internet and prescribed by licensed physicians online and A New Obesity Drug Delivered

Be sure to tell your prescriber about any side effects you experience, especially if theyre severe or persistent

Food moves too slowly (or not at all) from the stomach to the small intestine

A burst rating indicates the battery discharge rate for short bursts (a few seconds maximum) of extended power

Lilly announced the deal with CVS on Thursday about a year after its insurance plans picked up coverage of Novo Nordisk's Wegovy weight loss drug and dropped coverage of Zepbound

Thanks to the FDAs National Priority Voucher program Novo Nordisk should see the FDA's decision within one to two months, resulting in high dose semaglutide availability in 2026